These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6812140)

  • 1. Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect--a phase II study.
    Pedersen OL; Kragh-Sørensen P; Bjerre M; Overø KF; Gram LF
    Psychopharmacology (Berl); 1982; 77(3):199-204. PubMed ID: 6812140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial, clinical trial of a new, specific 5-HT reuptake inhibitor, citalopram (Lu 10-171).
    Gottlieb P; Wandall T; Overø KF
    Acta Psychiatr Scand; 1980 Sep; 62(3):236-44. PubMed ID: 6935914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Open preliminary study of new antidepressive compound: citalopram].
    Ropert R; Lôo H; Gay C
    Encephale; 1984; 10(3):131-4. PubMed ID: 6594229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citalopram--a specific 5-HT-reuptake inhibitor--as an antidepressant drug: a phase II multicentre trail.
    Ofsti E
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):327-35. PubMed ID: 6959197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels.
    Bjerkenstedt L; Flyckt L; Overø KF; Lingjaerde O
    Eur J Clin Pharmacol; 1985; 28(5):553-7. PubMed ID: 3899675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthostatic side effects of clomipramine and citalopram during treatment for depression.
    Christensen P; Thomsen HY; Pedersen OL; Gram LF; Kragh-Sørensen P
    Psychopharmacology (Berl); 1985; 86(4):383-5. PubMed ID: 3929308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary studies with citalopram (LU 10-171), a specific 5-HT-reuptake inhibitor, as antidepressant.
    Gastpar M; Gastpar G
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):319-25. PubMed ID: 6959196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Danish University Antidepressant Group.
    Psychopharmacology (Berl); 1986; 90(1):131-8. PubMed ID: 2876451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor--a dose-response study in depressed patients.
    Bjerkenstedt L; Edman G; Flyckt L; Hagenfeldt L; Sedvall G; Wiesel FA
    Psychopharmacology (Berl); 1985; 87(3):253-9. PubMed ID: 3936081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citalopram--a highly selective 5-HT uptake inhibitor--in the treatment of depressed patients.
    Dufour H; Bouchacourt M; Thermoz P; Viala A; Phak Rop P; Gouezo F; Durand A; Høpfner Petersen HE
    Int Clin Psychopharmacol; 1987 Jul; 2(3):225-37. PubMed ID: 3320186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citalopram versus mianserin. A controlled, double-blind trial in depressed patients.
    de Wilde J; Mertens C; Overø KF; Petersen HE
    Acta Psychiatr Scand; 1985 Jul; 72(1):89-96. PubMed ID: 3898725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of citalopram (Lu 10-171) on the serotonin (5-HT) uptake kinetics in platelets from endogenously depressed patients.
    Beving H; Bjerkenstedt L; Malmgren R; Olsson P; Unge G
    J Neural Transm; 1985; 61(1-2):95-104. PubMed ID: 3856629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Citalopram. An open study of a highly selective serotonin-uptake inhibitor administered by infusion to depressive patients].
    Charbonnier JF; Reboul P; Rougier M; Aubin B; Chassaing JL; Philippe P; Planche R; Hoepfner Petersen HE
    Encephale; 1987; 13(4):249-54. PubMed ID: 3311709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
    Benfield P; Heel RC; Lewis SP
    Drugs; 1986 Dec; 32(6):481-508. PubMed ID: 2878798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison of citalopram (Lu 10-171) and amitriptyline in depressed patients.
    Gravem A; Amthor KF; Astrup C; Elgen K; Gjessing LR; Gunby B; Pettersen RD; Kyrdalen L; Vaadal J; Ofsti E
    Acta Psychiatr Scand; 1987 May; 75(5):478-86. PubMed ID: 3300171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of citalopram, a specific serotonin uptake inhibitor, in tardive dyskinesia and parkinsonism.
    Korsgaard S; Noring U; Povlsen UJ; Gerlach J
    Clin Neuropharmacol; 1986; 9(1):52-7. PubMed ID: 3470139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline. A preliminary study.
    Møller SE; de Beurs P; Timmerman L; Tan BK; Leijnse-Ybema HJ; Stuart MH; Petersen HE
    Psychopharmacology (Berl); 1986; 88(1):96-100. PubMed ID: 3080781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram versus maprotiline: a controlled, clinical multicentre trial in depressed patients.
    Bouchard JM; Delaunay J; Delisle JP; Grasset N; Mermberg PF; Molczadzki M; Pagot R; Richou H; Robert G; Ropert R
    Acta Psychiatr Scand; 1987 Nov; 76(5):583-92. PubMed ID: 3324648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citalopram in doses of 20-60 mg is effective in depression relapse prevention: a placebo-controlled 6 month study.
    Robert P; Montgomery SA
    Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 1():29-35. PubMed ID: 7622809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the selective serotonin reuptake inhibitor citalopram on insulin sensitivity, leptin and basal cortisol secretion in depressed and non-depressed euglycemic women of reproductive age.
    Kauffman RP; Castracane VD; White DL; Baldock SD; Owens R
    Gynecol Endocrinol; 2005 Sep; 21(3):129-37. PubMed ID: 16335904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.